Position in PFE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,049,165
+$220,958 QoQ
Shares Held
72,976
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parkside Financial Bank & Trust holds $28,780,130 across 15 Drug Manufacturers - General names. PFE ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,749 | $7,127,297 | |
| 2 | ABBV |
AbbVie Inc.
|
28,631 | $6,226,955 | |
| 3 | JNJ |
Johnson & Johnson
|
20,434 | $4,994,886 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,825 | $3,106,488 | |
| 5 | PFE |
Pfizer Inc
This page
|
72,976 | $2,049,165 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,005 | $1,637,853 | |
| 7 | AMGN |
Amgen Inc
|
3,990 | $1,403,881 | |
| 8 | NVS |
Novartis AG
|
5,576 | $851,733 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,049,165 | 72,976 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,828,207 | 73,422 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,778,656 | 69,806 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,473,039 | 60,769 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,180,818 | 46,599 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,233,405 | 46,491 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,331,818 | 46,020 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,424,293 | 50,904 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,336,300 | 48,155 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,469,729 | 51,050 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,392,376 | 41,977 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,532,490 | 41,780 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,649,748 | 40,435 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,107,398 | 41,128 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,661,304 | 37,964 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,011,109 | 38,358 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,837,419 | 35,492 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,270,176 | 38,445 | Shares | Defined | 2022-03-01 | |
| 2021-09-30 | $1,577,864 | 36,686 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $1,464,035 | 37,386 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $1,341,705 | 37,033 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $1,404,521 | 38,156 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,214,621 | 33,096 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $1,259,507 | 38,517 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $1,217,143 | 37,290 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||